These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1112 related items for PubMed ID: 19077911

  • 1. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU, Reiser MF, Huber AM.
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [Abstract] [Full Text] [Related]

  • 2. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC, Inan N, Anik Y, Erturk MS, Ural D, Demirci A.
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K, Breuckmann F, Hunold P, Barkhausen J, Schlosser T.
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [Abstract] [Full Text] [Related]

  • 4. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine.
    Durmus T, Schilling R, Doeblin P, Huppertz A, Hamm B, Taupitz M, Wagner M.
    Invest Radiol; 2012 Mar; 47(3):183-8. PubMed ID: 22183078
    [Abstract] [Full Text] [Related]

  • 5. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Knopp MV, Runge VM, Essig M, Hartman M, Jansen O, Kirchin MA, Moeller A, Seeberg AH, Lodemann KP.
    Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
    [Abstract] [Full Text] [Related]

  • 6. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
    Huang B, Liang CH, Liu HJ, Wang GY, Zhang SX.
    Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla.
    Klumpp B, Fenchel M, Hoevelborn T, Helber U, Scheule A, Claussen C, Miller S.
    Invest Radiol; 2006 Sep; 41(9):661-7. PubMed ID: 16896300
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study.
    Cheong BY, Duran C, Preventza OA, Muthupillai R.
    AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638
    [Abstract] [Full Text] [Related]

  • 11. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
    Rudolph A, von Knobelsdorff-Brenkenhoff F, Wassmuth R, Prothmann M, Utz W, Schulz-Menger J.
    J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
    [Abstract] [Full Text] [Related]

  • 12. Gadobenate dimeglumine (Gd-DTPA) vs gadopentetate dimeglumine (Gd-BOPTA) for contrast-enhanced magnetic resonance angiography (MRA): improvement in intravascular signal intensity and contrast to noise ratio.
    Pediconi F, Fraioli F, Catalano C, Napoli A, Danti M, Francone M, Venditti F, Nardis P, Passariello R.
    Radiol Med; 2003 May; 106(1-2):87-93. PubMed ID: 12951555
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
    Schneider G, Altmeyer K, Kirchin MA, Seidel R, Grazioli L, Morana G, Saini S.
    Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
    Nural MS, Gokce E, Danaci M, Bayrak IK, Diren HB.
    Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine.
    Knopp MV, Giesel FL, von Tengg-Kobligk H, Radeleff J, Requardt M, Kirchin MA, Hentrich HR.
    J Magn Reson Imaging; 2003 Jun; 17(6):694-702. PubMed ID: 12766899
    [Abstract] [Full Text] [Related]

  • 19. Ultra low-dose of gadobenate dimeglumine for late gadolinium enhancement (LGE) imaging in acute myocardial infarction: a feasibility study.
    Galea N, Francone M, Zaccagna F, Ciolina F, Cannata D, Algeri E, Agati L, Catalano C, Carbone I.
    Eur J Radiol; 2014 Dec; 83(12):2151-2158. PubMed ID: 25293818
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.